News

Company News: ISA Pharmaceuticals’ Chief Scientific Officer Prof. Dr. Cornelis Melief Receives AACR-CRI Lloyd J. Old Award in Cancer Immunology 2019

Recognition for outstanding and innovative cancer research

ISA Pharmaceuticals B.V., a clinical-stage immuno-oncology company, today announced that its Chief Scientific Officer Prof. Dr. Cornelis Melief will receive the AACR-CRI Lloyd J. Old Award in Cancer Immunology 2019 from the American Association of Cancer Research (AACR) and the Cancer Research Institute. Read more…

Company News: Curetis’ Subsidiary Ares Genetics and QIAGEN Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance

— QIAGEN becomes exclusive partner for bioinformatics research applications based on ARESdb and AREStools

— Partnership intends to create a community platform for antimicrobial resistance research

Curetis N.V. (the “Company” and together with its subsidiaries “Curetis”), a developer of next-level molecular diagnostic solutions, today announced that its wholly-owned subsidiary Ares Genetics GmbH (Vienna, Austria) and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) have entered into a strategic licensing agreement for ARESdb and AREStools in the area of antimicrobial resistance (AMR) research. Read more…

Innovation Radar: Understanding science / Testing CRISPR-Cas9 in the lab

Last weekend, akampion went back to the lab for a day to get a first-hand experience of genome editing.  In an event organized by Science Bridge e.V. and supported by DFG, Joachim Herz Stiftung and Kassel University, selected participants were able to perform genome editing on an E. coli strain. Read more…

Heraeus PALACADEMY gets you into shape for cementing techniques and infection prevention

The courses and live events offered in 2019 by the Heraeus PALACADEMY provide orthopaedic and trauma surgeons, as well as specialist operating theatre staff, with many continuing education options for modern cementing techniques and infection management in arthroplasty. Registration is now open. Read more…

1 2 136